Published in Am J Trop Med Hyg on June 01, 2002
Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis (2009) 2.92
Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children. J Infect Dis (2012) 2.16
Impact of Plasmodium falciparum infection on haematological parameters in children living in Western Kenya. Malar J (2010) 1.68
Establishment of haematological and immunological reference values for healthy Tanzanian children in Kilimanjaro Region. Trop Med Int Health (2010) 1.56
Blood coagulation, inflammation, and malaria. Microcirculation (2008) 1.54
Is dengue and malaria co-infection more severe than single infections? A retrospective matched-pair study in French Guiana. Malar J (2012) 1.32
Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes. J Thromb Haemost (2006) 1.30
Does activation of the blood coagulation cascade have a role in malaria pathogenesis? Trends Parasitol (2008) 1.15
Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria-possible modulation in vivo by thrombocytopenia. J Infect Dis (2008) 1.07
Inter-relationships of cardinal features and outcomes of symptomatic pediatric Plasmodium falciparum MALARIA in 1,933 children in Kampala, Uganda. Am J Trop Med Hyg (2013) 1.06
Thrombocytopenia in Plasmodium vivax malaria is related to platelets phagocytosis. PLoS One (2013) 1.01
Delay in diagnosis of imported Plasmodium falciparum malaria in children. Eur J Clin Microbiol Infect Dis (2006) 1.01
Thrombocytopenia in vivax and falciparum malaria: an observational study of 131 patients in Karnataka, India. Ann Trop Med Parasitol (2011) 1.00
Hyponatraemia in imported malaria is common and associated with disease severity. Malar J (2010) 0.98
Epidemiological, clinical and biological features of malaria among children in Niamey, Niger. Malar J (2005) 0.96
Effect of malarial infection on haematological parameters in population near Thailand-Myanmar border. Malar J (2014) 0.96
Biomarkers of Plasmodium falciparum infection during pregnancy in women living in northeastern Tanzania. PLoS One (2012) 0.93
Biochemical and hematologic parameters for children in the middle belt of Ghana. Am J Trop Med Hyg (2014) 0.91
Altered platelet indices as potential markers of severe and complicated malaria caused by Plasmodium vivax: a cross-sectional descriptive study. Malar J (2013) 0.90
Complicated malaria and other severe febrile illness in a pediatric ward in Libreville, Gabon. BMC Infect Dis (2012) 0.89
Impact of asymptomatic Plasmodium falciparum parasitemia on the imunohematological indices among school children and adolescents in a rural area highly endemic for malaria in southern Mozambique. BMC Infect Dis (2013) 0.89
The platelet count in cerebral malaria, is it useful to the clinician? Am J Trop Med Hyg (2010) 0.87
Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia. J Infect Dis (2014) 0.86
Thrombocytopenia in African children can predict the severity of malaria caused by Plasmodium falciparum and the prognosis of the disease. Am J Trop Med Hyg (2003) 0.84
Testing in mice the hypothesis that melanin is protective in malaria infections. PLoS One (2012) 0.83
Developmental allometry and paediatric malaria. Malar J (2012) 0.82
Production, fate and pathogenicity of plasma microparticles in murine cerebral malaria. PLoS Pathog (2014) 0.81
Investigation on Plasmodium falciparum and Plasmodium vivax infection influencing host haematological factors in tribal dominant and malaria endemic population of Jharkhand. Saudi J Biol Sci (2013) 0.80
P. falciparum isolate-specific distinct patterns of induced apoptosis in pulmonary and brain endothelial cells. PLoS One (2014) 0.80
Outcome of life-threatening malaria in African children requiring endotracheal intubation. Malar J (2007) 0.78
Plasmodium falciparum malaria in a hypoendemic region in Senegal. Am J Trop Med Hyg (2003) 0.77
Thrombocytopenia May Mediate Disease Severity in Plasmodium falciparum Malaria Through Reduced Transforming Growth Factor Beta-1 Regulation of Proinflammatory and Anti-inflammatory Cytokines. Pediatr Infect Dis J (2015) 0.76
The impact of genetic susceptibility to systemic lupus erythematosus on placental malaria in mice. PLoS One (2013) 0.75
Effect of Plasmodium falciparum malaria parasites on haematological parameters in Ghanaian children. J Parasit Dis (2014) 0.75
Hematological Parameters and Hemozoin-Containing Leukocytes and Their Association with Disease Severity among Malaria Infected Children: A Cross-Sectional Study at Pawe General Hospital, Northwest Ethiopia. Interdiscip Perspect Infect Dis (2017) 0.75
New insights into the protective power of platelets in malaria infection. Commun Integr Biol (2013) 0.75
Thrombocytopenia in Plasmodium vivax Malaria: How Significant? J Trop Med (2014) 0.75
Severe imported malaria in children in France. A national retrospective study from 1996 to 2005. PLoS One (2017) 0.75
Clinical and laboratory predictors of death in African children with features of severe malaria: a systematic review and meta-analysis. BMC Med (2017) 0.75
Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis (2011) 7.42
Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomised controlled trial. Lancet Infect Dis (2012) 4.44
Protective efficacy of lambda-cyhalothrin treated nets in Anopheles gambiae pyrethroid resistance areas of Côte d'Ivoire. Am J Trop Med Hyg (2005) 2.89
Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet (2006) 2.77
Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J (2009) 2.76
Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J (2010) 2.75
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med (2007) 2.54
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am J Trop Med Hyg (2006) 2.34
The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood (2010) 2.17
A neonatal agranulocytosis. Clin Chem (2014) 2.01
Combating malaria in Africa. Trends Parasitol (2002) 1.98
Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg (2006) 1.97
Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis (2010) 1.89
Quantitative assessment of sensing and sequestration of spherocytic erythrocytes by the human spleen. Blood (2012) 1.87
Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J Clin Microbiol (2006) 1.74
Highly focused anopheline breeding sites and malaria transmission in Dakar. Malar J (2009) 1.63
Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Microbes Infect (2007) 1.63
Vivax malaria in Mauritania includes infection of a Duffy-negative individual. Malar J (2011) 1.63
Malaria infection and disease in an area with pyrethroid-resistant vectors in southern Benin. Malar J (2010) 1.59
Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob Agents Chemother (2009) 1.59
Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Blood (2008) 1.58
Social and environmental malaria risk factors in urban areas of Ouagadougou, Burkina Faso. Malar J (2009) 1.57
The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood (2010) 1.52
Left upper quadrant abdominal pain in malaria: suspect pathological splenic rupture first. Trans R Soc Trop Med Hyg (2010) 1.50
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs. Malar J (2011) 1.40
Cerebral haemorrhagic risk in children with sickle-cell disease. Dev Med Child Neurol (2014) 1.40
Scalp eschar and neck lymphadenopathy caused by Bartonella henselae after Tick Bite. Clin Infect Dis (2010) 1.40
Implication of haematophagous arthropod salivary proteins in host-vector interactions. Parasit Vectors (2011) 1.39
Ex vivo perfusion of human spleens maintains clearing and processing functions. Blood (2005) 1.39
Malaria transmission in Dakar: a two-year survey. Malar J (2008) 1.38
An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am J Trop Med Hyg (2006) 1.35
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrob Agents Chemother (2007) 1.33
Changing malaria epidemiology and diagnostic criteria for Plasmodium falciparum clinical malaria. PLoS One (2012) 1.33
Comparative performances, under laboratory conditions, of seven pyrethroid insecticides used for impregnation of mosquito nets. Bull World Health Organ (2003) 1.33
Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J (2010) 1.31
Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline. Antimicrob Agents Chemother (2008) 1.29
Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis (2010) 1.27
Malaria incidence in relation to rice cultivation in the irrigated Sahel of Mali. Acta Trop (2004) 1.25
Spatial heterogeneity and temporal evolution of malaria transmission risk in Dakar, Senegal, according to remotely sensed environmental data. Malar J (2010) 1.25
Possible autochthonous malaria from Marseille to Minneapolis. Emerg Infect Dis (2007) 1.22
The use of remotely sensed environmental data in the study of malaria. Geospat Health (2011) 1.22
Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes. Haematologica (2006) 1.21
Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. PLoS One (2008) 1.20
Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania. J Antimicrob Chemother (2011) 1.19
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Malar J (2010) 1.19
Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers. J Infect Dis (2010) 1.18
Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers. Am J Trop Med Hyg (2006) 1.13
Epidemiological and clinical aspects of blackwater fever among African children suffering frequent malaria attacks. Trans R Soc Trop Med Hyg (2003) 1.12
Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg Infect Dis (2010) 1.11
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J (2010) 1.11
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs. Antimicrob Agents Chemother (2011) 1.10
Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother (2009) 1.10
Diagnostic criteria and risk factors for Plasmodium ovale malaria. J Infect Dis (2002) 1.10
Malaria prevalence and morbidity among children reporting at health facilities in Nouakchott, Mauritania. Trans R Soc Trop Med Hyg (2011) 1.10
Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum. Antimicrob Agents Chemother (2010) 1.10
Antimalarial drug use in general populations of tropical Africa. Malar J (2008) 1.09
Chloroquine resistance reversal agents as promising antimalarial drugs. Curr Drug Targets (2006) 1.09
Conditions of malaria transmission in Dakar from 2007 to 2010. Malar J (2011) 1.08
In vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti. Antimicrob Agents Chemother (2006) 1.08
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum. Antimicrob Agents Chemother (2008) 1.06
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J (2012) 1.06
Malaria transmission and insecticide resistance of Anopheles gambiae in Libreville and Port-Gentil, Gabon. Malar J (2010) 1.06
Multiple independent introductions of Plasmodium falciparum in South America. Proc Natl Acad Sci U S A (2011) 1.06
Entomological and parasitological impacts of indoor residual spraying with DDT, alphacypermethrin and deltamethrin in the western foothill area of Madagascar. Malar J (2014) 1.05
Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base. Malar J (2009) 1.05
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum. Malar J (2010) 1.05
Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene. J Antimicrob Chemother (2010) 1.04
IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal. Malar J (2012) 1.03
Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay. Malar J (2007) 1.02
Regression of severe tungiasis-associated morbidity after prevention of re-infestation: a case series from rural Madagascar. Am J Trop Med Hyg (2013) 1.01
The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens. Microbes Infect (2008) 1.01
Persisting mixed cryoglobulinemia in Chikungunya infection. PLoS Negl Trop Dis (2009) 1.00
Malaria transmission and insecticide resistance of Anopheles gambiae (Diptera: Culicidae) in the French military camp of Port-Bouët, Abidjan (Côte d'Ivoire): implications for vector control. J Med Entomol (2006) 1.00
Heritability of the human infectious reservoir of malaria parasites. PLoS One (2010) 1.00
The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance. ACS Chem Biol (2011) 0.99
First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America. Antimicrob Agents Chemother (2007) 0.99
Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica (2011) 0.98
Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa. Malar J (2010) 0.98
Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs. Malar J (2011) 0.98
Nationwide evaluation of malaria infections, morbidity, mortality, and coverage of malaria control interventions in Madagascar. Malar J (2014) 0.97
Plasmodium falciparum proteome changes in response to doxycycline treatment. Malar J (2010) 0.96
Identification of cellular proteome modifications in response to West Nile virus infection. Mol Cell Proteomics (2009) 0.96
Salivary gland protein repertoire from Aedes aegypti mosquitoes. Vector Borne Zoonotic Dis (2010) 0.95
High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana. Am J Trop Med Hyg (2009) 0.94
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum. Malar J (2012) 0.94
Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts. PLoS One (2011) 0.93
Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malaria. Med Chem (2008) 0.92
Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting. BMC Microbiol (2009) 0.92
Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Curr Top Med Chem (2008) 0.92
Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites. Am J Trop Med Hyg (2012) 0.92
Risk factors for reinvasion of human dwellings by sylvatic triatomines in northern Bahia State, Brazil. Cad Saude Publica (2005) 0.92
Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum. Malar J (2010) 0.91
Risk mapping of Anopheles gambiae s.l. densities using remotely-sensed environmental and meteorological data in an urban area: Dakar, Senegal. PLoS One (2012) 0.91
Population genetics analysis during the elimination process of Plasmodium falciparum in Djibouti. Malar J (2013) 0.90
Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin. Antimicrob Agents Chemother (2009) 0.90
Prevention of tungiasis and tungiasis-associated morbidity using the plant-based repellent Zanzarin: a randomized, controlled field study in rural Madagascar. PLoS Negl Trop Dis (2013) 0.90
New protective battle-dress impregnated against mosquito vector bites. Parasit Vectors (2010) 0.90